Moderna/Merck’s Combo Melanoma Cancer mRNA Therapeutic May Be Ready Next Year
The CEO of Moderna, Inc., Stephane Bancel, said last week that his company may introduce a new mRNA (messenger ribonucleic acid) biologic to treat melanoma cancer as early as 2025. Moderna has been working in partnership with Merck, Inc. to develop a mRNA-based shot that targets skin cancer cells. The product, mRNA-4157 (V940), would be […]
Cancer Rates Rising Among People Under 50 Years Old
A 2022 study published in the journal Nature Reviews Clinical Oncology shows that incidence of cancers in adults under 50 years old has been increasing in the United States and many parts of the world since the 1990s.1 According to the National Cancer Institute (NCI), the rate of early-onset cancer cases in the U.S. grew […]
Guillain-Barré Syndrome Linked to the RSV Vaccine
The potential risk of Guillain-Barré syndrome (GBS) developing after receipt of Pfizer’s respiratory experimental syncytial virus (RSV) vaccine have prompted the U.S. Food and Drug Administration (FDA) to request that Pfizer conduct a post-marketing safety study if the vaccine is approved for use in the United States this spring.1 The RSV vaccine manufactured by GlaxoSmithKline […]
New Technology to Store Vaccination History in the Body
The Massachusetts Institute of Technology (MIT) News reported that researchers at the university have developed a way to record a person’s vaccination history and store the data in a pattern of dye, invisible to the naked eye, by infusing it under the skin at the same time the vaccine is given.1 The idea is to […]
Half of Americans Will Be Diagnosed With Cancer by 2030
Cancer is an “abnormal growth of cells.” That is perhaps the most succinct description of the disease, which is really more a group of diseases since there are more than 100 types of cancer. Cancer cells are malignant—meaning that they can invade and spread to different parts of the body, forming solid tumors (masses of […]
